218 related articles for article (PubMed ID: 19077116)
1. Genotype differences in cognitive functioning in Noonan syndrome.
Pierpont EI; Pierpont ME; Mendelsohn NJ; Roberts AE; Tworog-Dube E; Seidenberg MS
Genes Brain Behav; 2009 Apr; 8(3):275-82. PubMed ID: 19077116
[TBL] [Abstract][Full Text] [Related]
2. The language phenotype of children and adolescents with Noonan syndrome.
Pierpont EI; Ellis Weismer S; Roberts AE; Tworog-Dube E; Pierpont ME; Mendelsohn NJ; Seidenberg MS
J Speech Lang Hear Res; 2010 Aug; 53(4):917-32. PubMed ID: 20543023
[TBL] [Abstract][Full Text] [Related]
3. PTPN11, SOS1, KRAS, and RAF1 gene analysis, and genotype-phenotype correlation in Korean patients with Noonan syndrome.
Ko JM; Kim JM; Kim GH; Yoo HW
J Hum Genet; 2008; 53(11-12):999-1006. PubMed ID: 19020799
[TBL] [Abstract][Full Text] [Related]
4. Co-occurring PTPN11 and SOS1 gene mutations in Noonan syndrome: does this predict a more severe phenotype?
Brasil AS; Malaquias AC; Wanderley LT; Kim CA; Krieger JE; Jorge AA; Pereira AC; Bertola DR
Arq Bras Endocrinol Metabol; 2010 Nov; 54(8):717-22. PubMed ID: 21340158
[TBL] [Abstract][Full Text] [Related]
5. PTPN11 and KRAS gene analysis in patients with Noonan and Noonan-like syndromes.
Brasil AS; Pereira AC; Wanderley LT; Kim CA; Malaquias AC; Jorge AA; Krieger JE; Bertola DR
Genet Test Mol Biomarkers; 2010 Jun; 14(3):425-32. PubMed ID: 20578946
[TBL] [Abstract][Full Text] [Related]
6. [SOS1 mutation: a new cause of Noonan syndrome].
Serrano-Martín MM; Martínez-Aedo MJ; Tartaglia M; López-Siguero JP
An Pediatr (Barc); 2008 Apr; 68(4):365-8. PubMed ID: 18394382
[TBL] [Abstract][Full Text] [Related]
7. External ear anomalies and hearing impairment in Noonan Syndrome.
van Trier DC; van Nierop J; Draaisma JMT; van der Burgt I; Kunst H; Croonen EA; Admiraal RJC
Int J Pediatr Otorhinolaryngol; 2015 Jun; 79(6):874-878. PubMed ID: 25862627
[TBL] [Abstract][Full Text] [Related]
8. Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations.
Athota JP; Bhat M; Nampoothiri S; Gowrishankar K; Narayanachar SG; Puttamallesh V; Farooque MO; Shetty S
BMC Med Genet; 2020 Mar; 21(1):50. PubMed ID: 32164556
[TBL] [Abstract][Full Text] [Related]
9. Noonan and cardio-facio-cutaneous syndromes: two clinically and genetically overlapping disorders.
Nyström AM; Ekvall S; Berglund E; Björkqvist M; Braathen G; Duchen K; Enell H; Holmberg E; Holmlund U; Olsson-Engman M; Annerén G; Bondeson ML
J Med Genet; 2008 Aug; 45(8):500-6. PubMed ID: 18456719
[TBL] [Abstract][Full Text] [Related]
10. Genotype-phenotype correlation analysis in Japanese patients with Noonan syndrome.
Shoji Y; Ida S; Niihori T; Aoki Y; Okamoto N; Etani Y; Kawai M
Endocr J; 2019 Nov; 66(11):983-994. PubMed ID: 31292302
[TBL] [Abstract][Full Text] [Related]
11. Targeted/exome sequencing identified mutations in ten Chinese patients diagnosed with Noonan syndrome and related disorders.
Xu S; Fan Y; Sun Y; Wang L; Gu X; Yu Y
BMC Med Genomics; 2017 Oct; 10(1):62. PubMed ID: 29084544
[TBL] [Abstract][Full Text] [Related]
12. Cognitive profile of disorders associated with dysregulation of the RAS/MAPK signaling cascade.
Cesarini L; Alfieri P; Pantaleoni F; Vasta I; Cerutti M; Petrangeli V; Mariotti P; Leoni C; Ricci D; Vicari S; Selicorni A; Tartaglia M; Mercuri E; Zampino G
Am J Med Genet A; 2009 Feb; 149A(2):140-6. PubMed ID: 19133693
[TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular characterization of children with Noonan syndrome and other RASopathies in Argentina.
Chinton J; Huckstadt V; Moresco A; Gravina LP; Obregon MG
Arch Argent Pediatr; 2019 Oct; 117(5):330-337. PubMed ID: 31560489
[TBL] [Abstract][Full Text] [Related]
14. Learning and memory in children with Noonan syndrome.
Pierpont EI; Tworog-Dube E; Roberts AE
Am J Med Genet A; 2013 Sep; 161A(9):2250-7. PubMed ID: 23918208
[TBL] [Abstract][Full Text] [Related]
15. The face of Noonan syndrome: Does phenotype predict genotype.
Allanson JE; Bohring A; Dörr HG; Dufke A; Gillessen-Kaesbach G; Horn D; König R; Kratz CP; Kutsche K; Pauli S; Raskin S; Rauch A; Turner A; Wieczorek D; Zenker M
Am J Med Genet A; 2010 Aug; 152A(8):1960-6. PubMed ID: 20602484
[TBL] [Abstract][Full Text] [Related]
16. Co-occurring SHOC2 and PTPN11 mutations in a patient with severe/complex Noonan syndrome-like phenotype.
Ekvall S; Hagenäs L; Allanson J; Annerén G; Bondeson ML
Am J Med Genet A; 2011 Jun; 155A(6):1217-24. PubMed ID: 21548061
[TBL] [Abstract][Full Text] [Related]
17. Germline gain-of-function mutations in SOS1 cause Noonan syndrome.
Roberts AE; Araki T; Swanson KD; Montgomery KT; Schiripo TA; Joshi VA; Li L; Yassin Y; Tamburino AM; Neel BG; Kucherlapati RS
Nat Genet; 2007 Jan; 39(1):70-4. PubMed ID: 17143285
[TBL] [Abstract][Full Text] [Related]
18. Differential allelic expression of SOS1 and hyperexpression of the activating SOS1 c.755C variant in a Noonan syndrome family.
Moncini S; Bonati MT; Morella I; Ferrari L; Brambilla R; Riva P
Eur J Hum Genet; 2015 Nov; 23(11):1531-7. PubMed ID: 25712082
[TBL] [Abstract][Full Text] [Related]
19. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity.
Tartaglia M; Kalidas K; Shaw A; Song X; Musat DL; van der Burgt I; Brunner HG; Bertola DR; Crosby A; Ion A; Kucherlapati RS; Jeffery S; Patton MA; Gelb BD
Am J Hum Genet; 2002 Jun; 70(6):1555-63. PubMed ID: 11992261
[TBL] [Abstract][Full Text] [Related]
20. Clinical manifestations in patients with SOS1 mutations range from Noonan syndrome to CFC syndrome.
Narumi Y; Aoki Y; Niihori T; Sakurai M; Cavé H; Verloes A; Nishio K; Ohashi H; Kurosawa K; Okamoto N; Kawame H; Mizuno S; Kondoh T; Addor MC; Coeslier-Dieux A; Vincent-Delorme C; Tabayashi K; Aoki M; Kobayashi T; Guliyeva A; Kure S; Matsubara Y
J Hum Genet; 2008; 53(9):834-841. PubMed ID: 18651097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
